Literature DB >> 11238442

The Venus's-flytrap and cysteine-rich domains of the human Ca2+ receptor are not linked by disulfide bonds.

J Hu1, G Reyes-Cruz, P K Goldsmith, A M Spiegel.   

Abstract

The extracellular N-terminal domain of the human Ca(2+) receptor (hCaR) consists of a Venus's-flytrap (VFT) domain and a cysteine-rich (Cys-rich) domain. We have shown earlier that the Cys-rich domain is critical for signal transmission from the VFT domain to the seven-transmembrane domain. The VFT domain contains 10 cysteines: two of them (Cys(129) and Cys(131)) were identified as involved in intermolecular disulfide bonds necessary for homodimerization, and six others (Cys(60)-Cys(101), Cys(358)-Cys(395), and Cys(437)-Cys(449)) are predicted to form three intramolecular disulfide bonds. The Cys-rich domain contains nine cysteines, the involvement of which in disulfide bond formation has not been defined. In this work, we asked whether the remaining cysteines in the hCaR VFT, namely Cys(236) and Cys(482), form disulfide bond(s) with cysteines in the Cys-rich domain. We constructed mutant hCaRs with a unique tobacco etch virus (TEV) protease recognition site inserted between the VFT domain and the Cys-rich domain. These mutant hCaRs remain fully functional compared with the wild type hCaR. After TEV protease digestion of the mutant hCaR proteins, dimers of the VFT were identified on Western blot under nonreducing conditions. We concluded that there is no disulfide bond between the VFT and the Cys-rich domains in the hCaR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238442     DOI: 10.1074/jbc.C000865200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  The modeling of the structure of the cysteine-rich domain of metabotropic glutamate receptors.

Authors:  M S Belenikin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2004 Jan-Feb       Impact factor: 0.788

Review 2.  Mechanisms of multimodal sensing by extracellular Ca(2+)-sensing receptors: a domain-based survey of requirements for binding and signalling.

Authors:  Mahvash A Khan; Arthur D Conigrave
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

3.  Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.

Authors:  A Mahajan; J Buse; G Kline
Journal:  Osteoporos Int       Date:  2019-10-23       Impact factor: 4.507

4.  Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor.

Authors:  Anson K Abraham; Tristan S Maurer; Amit S Kalgutkar; Xiang Gao; Mei Li; David R Healy; Donna N Petersen; David A Griffith; Donald E Mager
Journal:  AAPS J       Date:  2011-03-25       Impact factor: 4.009

Review 5.  Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators.

Authors:  Jianxin Hu; Allen M Spiegel
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.